Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY:JNJ)

189.81 -2.66 (-1.38%)
Streaming Delayed Price Updated: 12:49 PM EDT, Oct 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,508,748
Open 192.20
Bid (Size) 189.80 (2)
Ask (Size) 189.83 (3)
Prev. Close 192.47
Today's Range 189.60 - 192.31
52wk Range 140.68 - 194.48
Shares Outstanding 2,628,679,824
Dividend Yield 2.74%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
FDA Approves GSK's Withdrawn Blood Cancer Drug Blenrep
FDA approves GSK's Blenrep combo for relapsed multiple myeloma, showing 51% reduced death risk and tripled progression-free survival in Phase 3 trial. 
Via Benzinga
IMF Sounds Alarm: 'Shifting Ground Beneath the Calm' Threatens Global Financial Stability
Washington D.C. – October 23, 2025 – The International Monetary Fund (IMF) has today released its Global Financial Stability Report (GFSR) for October 2025, titled "Shifting Ground beneath the Calm,"... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy

Performance

YTD
+31.8%
+31.8%
1 Month
+7.5%
+7.5%
3 Month
+11.9%
+11.9%
6 Month
+22.5%
+22.5%
1 Year
+14.4%
+14.4%

More News

Read More
Flash PMI: The Early Warning System Guiding the Federal Reserve's Hand
Via MarketMinute
Topics Bonds Economy Supply Chain
Kenvue Stock Climbs Premarket, Day After Record Slide On UK Lawsuit: Retail Bulls Remain Unshaken
Via Stocktwits
Integer Holdings (ITGR) Shares Plunge 31.4% as Slower New Product Adoption and Revised Guidance Rock Investor Confidence
Via MarketMinute
Topics Earnings Supply Chain
Johnson & Johnson to Participate in the 7th Annual Wolfe Research Healthcare Conference
From Johnson & Johnson
Via Business Wire
Nurix Therapeutics (NASDAQ: NRIX) Stock Soars as Pivotal Phase 2 Study for Bexobrutideg Ignites Investor Confidence
Via MarketMinute
Intuitive Surgical Soars on Stellar Q3 2025 Earnings, Driven by Da Vinci 5 Adoption
Via MarketMinute
Topics Artificial Intelligence Earnings Intellectual Property
Boston Scientific Soars: Q3 2025 Earnings Beat Ignites Medical Device Market
Via MarketMinute
Topics Artificial Intelligence Earnings Economy
Ominous Echoes: U.S. Job Growth Stalls to 2009 Levels, Signaling Deep Labor Market Fragility
Via MarketMinute
Topics Artificial Intelligence Economy Supply Chain
Johnson & Johnson Draws Long-Term Buyers as Markets Turn Cautious
Via The Motley Fool
Topics Economy
IMF Sounds Alarm: Global Growth Slows, Developing Economies Face Mounting Debt Crisis
Via MarketMinute
Topics Bonds Economy World Trade
Johnson Y-Axis Adjustment(R) (\"Ring Dinger(R)\") Clarified as In-Scope Care Under Texas Law; Advanced Chiropractic Equipment LLC Addresses Confusion with Y-Strap Traction
Via Newsfile
The Industrial Giant's Resurgence: Why 3M (NYSE: MMM) Is Poised to Outperform the S&P 500 Over the Next Decade
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
Q3 2025 Earnings Season: A High-Stakes Quarter for Market Direction
Via MarketMinute
Topics Artificial Intelligence Earnings Economy
Global Trade Tensions: A Rollercoaster Ride for the Stock Market in October 2025
Via MarketMinute
Topics Economy Electric Vehicles Government
3 Dividend Stocks With 5% (or Higher) Yields to Buy Hand Over Fist in October
Via The Motley Fool
2 Top Dividend Kings Every Income Investor Should Own
Via The Motley Fool
Topics Bonds
Biotech Boom: Strategic Realignments and AI Integration Fuel Investor Focus, Signaling Broader Market Shifts
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
Global Economic Headwinds Intensify as China's Q3 GDP Forecast Signals Year-Low Growth, Sending Ripples Through International Markets
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
Meet the 5%-Yielding Dividend Stock That Could Soar in 2026
Via The Motley Fool
Johnson & Johnson's M&A Strategy Is the Real Story for Investors
Via MarketBeat
Why Kenvue Stock Tumbled by 13% on Thursday
Via The Motley Fool
Topics Lawsuit
Global Markets Brace for Impact as Investor Risk Aversion Escalates Amidst Geopolitical Tensions and Economic Headwinds
Via MarketMinute
Topics Bonds Economy World Trade
Global Markets Brace for Turbulence: Credit Concerns and Geopolitical Tensions Fuel Volatility
Via MarketMinute
Topics Artificial Intelligence Bonds Economy

Frequently Asked Questions

Is Johnson & Johnson publicly traded?
Yes, Johnson & Johnson is publicly traded.
What exchange does Johnson & Johnson trade on?
Johnson & Johnson trades on the New York Stock Exchange
What is the ticker symbol for Johnson & Johnson?
The ticker symbol for Johnson & Johnson is JNJ on the New York Stock Exchange
What is the current price of Johnson & Johnson?
The current price of Johnson & Johnson is 189.81
When was Johnson & Johnson last traded?
The last trade of Johnson & Johnson was at 10/24/25 12:49 PM ET
What is the market capitalization of Johnson & Johnson?
The market capitalization of Johnson & Johnson is 498.95B
How many shares of Johnson & Johnson are outstanding?
Johnson & Johnson has 499B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.